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Abstract ALG-2 (apoptosis linked gene-2) is an essential pro-
tein for the execution of apoptosis whose function is largely
unknown. Here, we demonstrate that ALG-2 could interact
with the C-terminus (amino acids 941^1375) of the apoptosis
signal-regulating kinase 1 (ASK1) in BOSC23 cells as well as in
vitro. ASK1 failed to bind to an isotype of ALG-2 found in the
liver, ALG-2,1, in which two amino acids (Gly-121 and Phe-
122) are deleted. This implies that the interaction is very spe-
ci¢c. Cotransfection with ALG-2 resulted in the nuclear pres-
ence of ASK1 and inhibited the activation of c-Jun N-terminal
kinase (JNK) by ASK1 in BOSC23 cells. This study reports
that ALG-2 could regulate the subcellular localization and the
JNK activity modulation of ASK1 by direct interaction.
4 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis is a physiological process of cell death that is
essential for the animal development and adult homeostasis
[1,2]. Fas is a member of the tumor necrosis factor (TNF)
receptor family and induces apoptosis by binding to Fas li-
gand [3]. Fas can activate two independent signaling path-
ways. One well-characterized pathway involves the adapter
protein FADD, which recruits procaspase-8 and activates
the caspase cascade leading to apoptosis [1]. The second path-
way is mediated by Daxx, which interacts with apoptosis sig-
nal-regulating kinase 1 (ASK1) activating c-Jun N-terminal
kinase (JNK) and p38 MAPK (mitogen-activated protein ki-
nase) by phosphorylation [4].
Con£icting data exist regarding the correlation between
JNK activation and Fas-mediated apoptosis. There are re-
ports that JNK activation in£uences multiple proteins con-
trolling apoptosis such as c-Jun, p53 and Bax [5^7]. However,
it has also been reported that JNK activation is not required
for the execution of Fas-mediated cell killing [8,9].
ASK1 is a kinase that acts upstream of the JNK pathway
when stimulated by diverse stimuli such as TNF, Fas, H2O2,
oxidative stress, DNA damage and polyglutamine repeats [10^
15]. The association of thioredoxin with ASK1 promotes
ubiquitination/degradation of ASK1 leading to inhibition of
ASK1-induced apoptosis [16]. Overexpression of ASK1 in-
duces apoptosis through a mitochondria-dependent caspase
activation pathway and a dominant-negative mutant of
ASK1 inhibited apoptosis induced by TNF and Fas ligation
[11,12,17,18].
Several cellular factors such as Daxx, TRAF2 (TNF recep-
tor-associated factor 2), CDC25A, 14-3-3, thioredoxin and
protein phosphatase 5 (PP5), have been reported to bind
with ASK1 [19^23]. Daxx and TRAF2 activate the kinase
activity of ASK1, but CDC25A, 14-3-3, thioredoxin and
PP5 inhibit it [23]. ASK1 is localized in the cytoplasm and
Daxx in the nucleus [24,25]. However, Daxx translocates from
the nucleus to the cytoplasm after Fas ligation [26,29,30].
ASK1 binds to TRAF2 and this binding is essential for
JNK activation [15,19]. CDC25A binds to the C-terminus of
ASK1 and inhibits the kinase activity of ASK1. 14-3-3 can
inhibit the proapoptotic function of ASK1 through binding to
Ser-967 of ASK1, which is phosphorylated by an unknown
survival signaling kinase [21]. Thioredoxin in its reduced form
binds to the NH2-terminal part of ASK1 and blocks activa-
tion of ASK1 by TNF [13,20,28]. ASK1 also possesses a cas-
pase-independent apoptotic function that is independent of its
kinase activity [29].
ALG-2 (apoptosis-linked gene-2) is a protein whose absence
causes a failure in apoptosis induced by Fas, T cell receptors
and glucocorticoids [30]. However, ALG-2-de¢cient mice do
not seem to block apoptosis induced by various apoptotic
signals [31]. ALG-2 is a calpain small subunit subfamily of
Ca2þ binding proteins and contains a ¢ve EF-hand Ca2þ
binding domain [32,33]. ALG-2 seems to act downstream of
caspase activation because ALG-2 depletion does not a¡ect
caspase activation [35]. Since ALG-2 depletion blocks apopto-
sis, it implies that ALG-2 dissociates activation of caspases
from the apoptotic event. However, association of ALG-2
with Fas has been reported in Jurkat cells implying that
ALG-2 might work upstream of the signaling pathway or at
the signal ampli¢cation phase [36]. Interaction of human em-
bryonic ectoderm development protein was reported, implying
that ALG-2 might be involved in the anterior^posterior pat-
terning process [37]. Subcellular localization of ALG-2 does
not seem to be simple. ALG-2 exists in the cytoplasm of L66
¢broblast cells and in the membrane and in the nucleus of
Jurkat cells [36,38,39]. Thus, ALG-2 might work in di¡erent
subcellular spaces depending on the cell type or the physio-
logical conditions.
ALG-2,1, an isotype of ALG-2 missing two internal amino
acids (Gly-121 and Phe-122), was found in the mouse liver
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[40]. ALG-2,1 forms heterodimers with ALG-2,5, a predom-
inant ALG-2 isotype containing Gly-121 and Phe-122 (ALG-2
means ALG-2,5 isotype in this study). The heterodimerization
of ALG-2 with pe£in plays a role in the stabilization of pe£in
[41]. ALG-2 binds to AIP-1 (ALG-2 interacting protein 1)
whose yeast homolog is a member of the MAPK pathway
and also binds to the N-terminal region of annexin XI [42].
However, ALG-2,1 could not bind to AIP-1 [38,40]. Thus, it
has been proposed that the two ALG-2 isoforms might have
regulatory functions against each other.
The interaction between ALG-2 and ASK1 was examined
in this study, based on the fact that ASK1 is recruited to Fas
upon Fas activation and that ASK1 is a member of the
MAPK pathway. Here, we report that ASK1 could bind to
ALG-2 and that this interaction would in£uence subcellular
localization and the JNK activation of ASK1.
2. Materials and methods
2.1. Plasmids
pcDNA3/ASK1-HA was a gift from Dr. K.S. Kwon (Korea Re-
search Institute of Bioscience and Biotechnology, Seoul, South
Korea). PGEX-4T-1/ASK1 N648 (amino acids (a.a.) 1^648),
pGEX4T-1/ASK1 KK (a.a. 649^940) and pGEX4T-1/ASK1 KC
(a.a. 941^1375), respectively, were produced by polymerase chain re-
action (PCR) using pcDNA3/ASK1-HA as a template. pFLAG-
CMV-5a/ALG-2, pGEX4T-1/ALG-2, pGEX4T-1/ALG-2-23N (a.a.
24^191), and pGEX4T-1/ALG-2,1 constructs were produced by
PCR using pcDNA3/ALG-2 [36] as a template.
2.2. Cell lines, culture conditions and transfections
BOSC23 cells were grown at 37‡C in 5% CO2 in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) (Hyclone, Logan, UT, USA) and antibiotics (Invitrogen,
Carlsbad, CA, USA). 1U106 BOSC23 cells were transfected with in-
dicated plasmids using the calcium phosphate method.
2.3. In vitro binding assays
GST-ALG-2 was expressed in Escherichia coli and puri¢ed with
glutathione-agarose beads. ASK1 was translated in vitro in the pres-
ence of [35S]methionine using the TNT reticulocyte lysate system
(Promega, Madison, WI, USA). The 35S-labeled proteins were incu-
bated at 4‡C for 3 h with the GST-ALG-2 immobilized onto the beads
in the binding bu¡er containing 50 mM HEPES (pH 7.6), 50 mM
NaCl, 5 mM EDTA, 0.1% Nonidet P-40, and 10% glycerol. The beads
were harvested and washed three times with the binding bu¡er. The
35S-labeled proteins were then eluted from the beads and analyzed by
SDS^PAGE and autoradiography.
2.4. Western blotting
Cells were washed once with phosphate-bu¡ered saline (PBS) and
harvested from the culture dishes using trypsin. The cell pellets were
subsequently lysed in the mammalian lysis bu¡er (50 mM Tris^HCl
(pH 8.0), 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.4 mM
phenylmethylsulfonyl £uoride). After lysis, the cell extract was soni-
cated and centrifuged at 13 000 rpm. Protein (30 Wg) from the total
cell lysate was separated by electrophoresis on a SDS^PAGE gel and
transferred to a polyvinylidene di£uoride membrane (Millipore, Bed-
ford, MA, USA). The membrane was probed with mouse anti-FLAG
monoclonal antibody (Sigma, St. Louis, MO, USA) at a dilution of
1:2000, rabbit anti-hemagglutinin (HA) antibody (Santa Cruz, Santa
Cruz, CA, USA) at a dilution of 1:1000, and rabbit anti-ALG-2 anti-
body (gift from Dr. J.W. Kim, PaiChai University, Taejon, South
Fig. 1. Interaction between ASK1 and ALG-2 in vivo (A) and in vitro (B). A: BOSC23 cells were transfected with pFLAG-CMV-5a or
pFLAG-CMV-5a/ALG-2 and pcDNA3/ASK1-HA. ALG-2 was immunoprecipitated with mouse anti-FLAG antibody and Western blot was
carried out with rabbit anti-HA antibody. B: GST-ALG-2 proteins were puri¢ed and immobilized on glutathione Sepharose 4B beads. The
beads were incubated at 4‡C for 3 h with 35S-labeled ASK1 protein in the presence of EGTA or di¡erent concentrations of Ca2þ. After wash-
ing three times, the mixtures were resolved on a 6% SDS^PAGE gel and autoradiographed. Numbers on the left indicate protein molecular
weight standards in kDa. WCL, whole cell lysate.
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Korea) at a dilution of 1:1000 followed by AP-conjugated goat anti-
mouse IgG and anti-rabbit IgG antibodies (Santa Cruz).
2.5. Coimmunoprecipitation analysis
For coimmunoprecipitation experiment, cells were washed in cold
PBS, then lysed in the mammalian lysis bu¡er. Mouse anti-
FLAG0M2 a⁄nity gel (Sigma) was added to the cell lysate and in-
cubated for 4 h at 4‡C with gentle inversion mixing. After incubation
for 4 h, the gel was collected and washed three times with the mam-
malian lysis bu¡er. Coimmunoprecipitated proteins were analyzed by
SDS^PAGE and Western blot using anti-FLAG and anti-HA anti-
bodies.
2.6. Immuno£uorescence analysis
BOSC23 cells were grown on glass coverslips for 24 h in DMEM
containing 10% FBS and transfected with the pFLAG-CMV-5a/ALG-
2 and pcDNA3/ASK1-HA expression vectors. After transfection, cells
were ¢xed at room temperature for 20 min with 4% paraformaldehyde
in PBS and rinsed with 1UPBS containing 10% goat normal serum
(Sigma) and incubated with mouse anti-FLAG antibody (at 1:500
dilution) and rabbit anti-HA antibody (at 1:200 dilution) for 1 h.
After washing cells three times with 1UPBS, cells were incubated
with secondary anti-mouse IgG antibody (at 1:1000 dilution) conju-
gated with FITC-green (PharMingen, San Diego, CA, USA) and anti-
rabbit IgG antibody (at 1:1000 dilution) conjugated with TRITC-red
(Sigma) for 1 h. After extensive washing, slides were mounted and
confocal laser scanning microscopy was performed with Radiance
2000 confocal microscope (Bio-Rad, Hercules, CA, USA), using ex-
citation wavelengths of 494 nm (FITC-green) and 543 nm (TRITC-
red).
2.7. JNK activity assay
BOSC23 cells at 60^70% con£uence were transfected and incubated
in DMEM containing 10% serum for 24 h after transfection. Subse-
quently, BOSC23 cells were incubated in serum-free DMEM for an
additional 12 h. To measure JNK activity, cells were washed twice in
1UPBS and immediately lysed in the mammalian lysis bu¡er and
sonicated. After sonication, cells were centrifuged at 13 000 rpm and
cell debris was removed. 100 Wg of cell lysate was incubated with
recombinant GST-c-Jun (a.a. 1^79) bound to glutathione-coupled
beads. Kinase assay was performed for 30 min at 30‡C in a ¢nal
reaction mixture of 100 Wl consisting of 200 Wg cell lysate, 15 WM
ATP, 10 WCi [Q-32P]ATP and 5 Wg of recombinant GST-c-Jun in ki-
nase bu¡er (20 mM MOPS, 2 mM EGTA, 10 mM MgCl2, 1 mM
dithiothreitol, 0.1% Triton X-100, 0.1 mM Na3VO4). The reactions
were terminated with SDS sample bu¡er and were subsequently boiled
for 3 min before separation on a 10% SDS^PAGE gel. Phosphoryla-
tion of GST-c-Jun was detected by autoradiography of the dried gels.
Transfection e⁄ciency of cells was judged by Western blotting with
anti-ALG-2, anti-HA and anti-JNK1 antibodies (PharMingen).
3. Results
3.1. ALG-2 interacts with ASK1
Since ALG-2 bound to Fas in Jurkat cells [36], we ques-
tioned if ALG-2 interacts with ASK1 which is recruited to Fas
upon Fas activation. In order to examine the interaction be-
tween ALG-2 and ASK1 in mammalian cells, pFLAG-CMV-
5a/ALG-2 and pcDNA3/ASK1-HA were transiently trans-
fected in BOSC23 cells. As shown in Fig. 1A, ASK1 was
detected by Western blot analysis with rabbit anti-HA anti-
body after immunoprecipitation with anti-FLAG antibody
implying that ASK1 could interact with ALG-2 in mamma-
lian cells.
ALG-2 is a calcium binding protein and showed di¡erential
interaction characteristics in the presence of Ca2þ, i.e. binding
to AIP with Ca2þ [38,43] but dissociating from pe£in with
Ca2þ [39]. Thus, the calcium dependence of the binding be-
tween ASK1 and ALG-2 was investigated. GST-ALG-2 fu-
sion protein pulled down the in vitro translated ASK1 with
nanomolar to millimolar concentrations of Ca2þ (Fig. 1B).
ALG-2 bound to ASK1 even in the presence of 5 mM
EGTA in the in vitro binding assay. Thus, the interaction
between ASK1 and ALG-2 was not in£uenced by the presence
of Ca2þ.
ASK1 could bind in vitro to the N-terminal deletion mutant
of ALG-2 in which the hydrophobic stretch of N-terminal 23
amino acids is deleted, meaning that the PEF (penta EF)
Fig. 2. Speci¢city of the interaction between ASK1 and ALG-2.
GST-ALG-2, GST-ALG-2-23N (a.a. 24^191 of ALG-2) and GST-
ALG-2,1 proteins were puri¢ed and bound to 35S-labeled ASK1 in
the bu¡er with 2 WM Ca2þ (upper panel). The amount of GST fu-
sion protein in the beads was revealed by Coomassie blue staining
(lower panel). Numbers on the left indicate protein molecular weight
standards in kDa.
Fig. 3. Binding of ALG-2 to the C-terminus of ASK1. GST-ASK1-
N648 (a.a. 1^648), GST-ASK1-KK (a.a. 649^940) and GST-ASK1-
KC (a.a. 941^1375) proteins were puri¢ed and bound to 35S-labeled
ALG-2 (upper panel). The amount of GST fusion protein in the
beads was revealed by Coomassie blue staining (lower panel). Num-
bers on the left indicate protein molecular weight standards in kDa.
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domain is su⁄cient for the binding (Fig. 2). However, GST
fusion protein of ALG-2,1 failed to pull down in vitro trans-
lated ASK1. This suggests that the binding between ASK1
and ALG-2 is very speci¢c.
In order to map the interacting region of ASK1 to ALG-2,
ASK1 deletion mutants were generated as GST fusion pro-
teins. Among various deletion constructs, the C-terminal con-
struct with a.a. 941^1375 of ASK1 (ASK1-KC) was su⁄cient
to bind to ALG-2 in vitro (Fig. 3). Thus, ALG-2 adds itself to
the list of proteins binding to the C-terminus of ASK1 such as
14-3-3, CDC25A and TRAF2.
3.2. ALG-2 induces nuclear localization of ASK1
ASK1 has been found in the cytoplasm and has been re-
vealed to transduce Fas-induced apoptosis signal [13]. It has
been reported that ASK1 forced Daxx to stay in the cyto-
plasm through the physical interaction between ASK1 and
Daxx in 293 cells [27]. Thus, we questioned if ASK1 in£uences
the subcellular localization of ALG-2. Confocal microscopic
analysis was performed with anti-FLAG antibody using goat
anti-mouse IgG-FITC as a secondary antibody (for the detec-
tion of ALG-2) and anti-HA antibody using goat anti-rabbit
IgG-TRITC as a secondary antibody (for the detection of
ASK1) in BOSC23 cells. ASK1 was present in the cytoplasm
and ALG-2 was predominantly in the nucleus when trans-
fected separately. However, in cells where pFLAG-CMV-5a/
ALG-2 and pcDNA3/ASK1-HA were cotransfected, both
ASK1 and ALG-2 were predominantly localized in the nu-
cleus (Fig. 4). Thus, ALG-2 seems to force ASK1 to be
present in the nucleus by direct interaction with ASK1.
3.3. ALG-2 inhibits JNK activation by ASK1
ASK1 activates JNK when localized in the cytoplasm. Since
ASK1 was present in the nucleus when cotransfected with
ALG-2, it is probable that the change in the localization of
ASK1 might in£uence the JNK activating function. To an-
swer this question, BOSC23 cells were transfected with
pcDNA3/ALG-2 and/or pcDNA3/ASK1-HA. Overexpression
of ALG-2 downregulated JNK activation whereas ASK1
overexpression activated JNK as previously reported by
others [11,12,17]. Moreover, in the cells cotransfected with
ALG-2 and ASK1, JNK activation by ASK1 was inhibited
signi¢cantly (Fig. 5). This implies that ALG-2 might inhibit
the JNK activation of ASK1 by changing the subcellular lo-
calization of ASK1.
4. Discussion
In this study, we demonstrated that ALG-2 could bind to
the C-terminus of ASK1 (a.a. 941^1375) and induced the nu-
clear localization of ASK1 and inhibited JNK activation by
ASK1. The interaction was speci¢c because deletion of two
internal amino acids of ALG-2 abrogated the interaction with
ASK1.
ALG-2 is a Ca2þ binding protein containing a PEF motif,
and exposes a hydrophobic surface in a Ca2þ-dependent man-
ner [32]. This conformational change seemed to be translated
into the di¡erential binding characteristics of ALG-2 depend-
ing upon the Ca2þ. ALG-2 dissociates from pe£in and binds
to AIP in a Ca2þ-dependent manner [32^34]. However, the
binding between ALG-2 and ASK1 was not dependent on
the presence of Ca2þ. This is the ¢rst report that ALG-2
interacts in a Ca2þ-independent manner.
ALG-2-23N mutant binds to ASK1 meaning that a hydro-
phobic amino acid stretch is not necessary for the interaction.
ALG-2,1, however, does not bind to ASK1. Thus, the inter-
action between ASK1 and ALG-2 seems to be speci¢c even if
it is not dependent upon the presence of Ca2þ. Considering
that ALG-2,1 and ALG-2,5 are endogenous isotypes, their
di¡erential binding characteristics with ASK1 provide an ele-
gant regulatory mechanism of ASK1-mediated signaling. For
instance, the stoichiometry of ALG-2 isotypes in cells would
be translated to their regulatory capacity upon ASK1.
The C-terminus of ASK1 was mapped for the binding to
14-3-3 and CDC25A. These interactions in the C-terminus of
ASK1 caused inhibition of ASK1’s kinase activity [20^22].
Fig. 4. Subcellular localization of ASK1 in BOSC23 cells. A:
BOSC23 cells were transfected with plasmid pFLAG-CMV-5a/ALG-
2 and pcDNA3/ASK1-HA. 72 h after transfection, the cells were
¢xed and processed for immuno£uorescence staining. B: Immuno-
£uorescence microphotographs showing the intracellular localization
of transfected ALG-2 and ASK1.
Fig. 5. E¡ect of ALG-2 upon activation of JNK by ASK1. In vitro
kinase assay showing the e¡ect of ALG-2 and ASK1 on JNK activ-
ity, BOSC23 cells were transfected pcDNA3/ALG-2 and pcDNA3/
ASK1-HA. The cells were lysed and 100 Wg of lysate was incubated
with 10 Wg of GST-c-Jun bound to glutathione beads. The kinase
reaction was performed in the presence of 10 WCi of [Q-32P]ATP for
30 min. The proteins were separated by SDS^PAGE and detected
by autoradiography. To measure relative levels of protein expres-
sion, cell lysates were separated on SDS^PAGE and immunoblotted
using indicated antibodies.
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ALG-2 interacts with the C-terminus of ASK1 and this inter-
action also inhibits ASK1’s downstream JNK activation.
ALG-2 seems to be localized in the cytoplasm and nucleus
depending on its cell type and physiological condition [36,39].
In this study, ALG-2 was found predominantly in the nucleus
of BOSC23 cells. Nuclear retention of ASK1 by cotransfec-
tion with ALG-2 would disconnect ASK1 physically from
activating JNK, a cytoplasmic protein. JNK activation is
often linked to cell death induced by stress, whereas cell death
can be prevented by inhibition of JNK activation [44,45].
Overexpression of ASK1 has been reported to activate the
JNK pathway in various cell lines. Nuclear retention of
ASK1 might prevent Daxx from being retained in the cyto-
plasm even though this has not been examined in this study. If
so, the nuclear presence of ASK1 would disturb the Daxx-
mediated apoptotic pathway. These data present a molecular
mechanism for the function of ALG-2, i.e. ALG-2 plays a
regulatory role on ASK1 by direct interaction.
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